+499.5%
MRNA vs POET
+56.2%
+443.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | POET | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +8.0% | -10.3% | -2.8% |
| 7D | +5.5% | +5.6% | -0.1% | +5.0% |
| 30D | +158.7% | -2.1% | +160.8% | +158.9% |
| 3M | +182.1% | -48.8% | +231.0% | +192.6% |
| 6M | +151.8% | +15.8% | +136.0% | +134.0% |
| YTD | +393.6% | +25.1% | +368.4% | +349.3% |
| 1Y | +499.5% | +50.6% | +448.9% | +452.9% |
| All | +499.5% | +56.2% | +443.3% | +452.9% |
Cumulative growth
Daily Returns
Daily percentage return beside POET.
Daily Out/Under-Performance
Portfolio return minus POET return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × POET return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded POET wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling